Artificial Intelligence

fortinet-simplifies-network-operations-by-enhancing-security-fabric-with-digital-experience-monitoring

Fortinet Simplifies Network Operations by Enhancing Security Fabric with Digital Experience Monitoring

fintech-enablement-company-enacomm-partners-with-bpo-contact-center-dialamerica-to-deliver-comprehensive-omnichannel-support

FinTech Enablement Company ENACOMM Partners with BPO Contact Center DialAmerica to Deliver Comprehensive Omnichannel Support

evisort-and-bny-mellon-to-digitize-contract-lifecycle-management

Evisort and BNY Mellon to Digitize Contract Lifecycle Management

a-rise-in-cyberattacks-such-as-ransomware-during-covid-19-boosted-security-skills-in-82%-of-it-teams,-sophos-survey-shows

A Rise in Cyberattacks Such as Ransomware During COVID-19 Boosted Security Skills in 82% of IT Teams, Sophos Survey Shows

omniq-receives-contract-to-deploy-ai-based-technology-at-philadelphia-international-airport

omniQ Receives Contract to Deploy AI Based Technology at Philadelphia International Airport

global-$8.14-bn-coworking-space-markets,-2015-2020,-2020-2025f,-2030f-–-open/conventional-coworking-spaces-&-corporate/professional-coworking-spaces

Global $8.14 Bn Coworking Space Markets, 2015-2020, 2020-2025F, 2030F – Open/Conventional Coworking Spaces & Corporate/Professional Coworking Spaces

onethree-biotech-joins-forces-with-sparc-to-characterize-a-key-oncologic-pathway

OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway

pensa’s-adoption-by-johnson-&-johnson,-general-mills-and-circle-k-points-to-expanded-demand-for-advanced-retail-shelf-intelligence

Pensa’s Adoption by Johnson & Johnson, General Mills and Circle K Points to Expanded Demand for Advanced Retail Shelf Intelligence

emerging-markets-report:-name-changed,-game-changed

Emerging Markets Report: Name Changed, Game Changed

anavex-life-sciences-announces-exceeding-of-enrollment-target-for-the-precision-medicine-anavex2-73-(blarcamesine)-phase-2b/3-clinical-trial-in-patients-with-alzheimer’s-disease

Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73 (blarcamesine) Phase 2b/3 Clinical Trial in Patients with Alzheimer’s Disease